RhumbLine Advisers’s BioLineRX BLRX Stock Holding History
Bought
Maintained
Sold
Other funds holding BLRX
RhumbLine Advisers's BLRX Position: Q3 2026 in Review
RhumbLine Advisers held its BioLineRX (BLRX) position steady in Q3 2026 at 2,478 shares worth $5.82K. The position accounts for ﹤0.01% of the portfolio, ranked #3876.
RhumbLine Advisers first reported a position in BLRX in Q3 2018 and has held it in 26 quarters since. The position peaked at $40K in Q3 2021. 17 funds tracked by Wall St. Rank hold BLRX as of Q3 2026.
- RhumbLine Advisers held 2,478 shares of BioLineRX worth $5.82K as of Q3 2026.
- RhumbLine Advisers left its BioLineRX share count unchanged in Q3 2026.
- BioLineRX made up ﹤0.01% of RhumbLine Advisers's portfolio in Q3 2026, its #3876 holding.
- RhumbLine Advisers first reported a position in BioLineRX in Q3 2018 and has held it in 26 quarters since.
- RhumbLine Advisers's BioLineRX position peaked at $40K in Q3 2021.
- 17 funds tracked by Wall St. Rank held BioLineRX as of Q3 2026.
Based on RhumbLine Advisers's 13F filing for Q3 2026, filed 10 Nov 2026.